China Eclinical Solutions Market Size & Outlook, 2023-2030
China eclinical solutions market, 2018-2030 (US$M)
Related Markets
China eclinical solutions market highlights
- The China eclinical solutions market generated a revenue of USD 595.6 million in 2023 and is expected to reach USD 1,657.2 million by 2030.
- The China market is expected to grow at a CAGR of 15.7% from 2024 to 2030.
- In terms of segment, ctms was the largest revenue generating product in 2023.
- ECOA is the most lucrative product segment registering the fastest growth during the forecast period.
Eclinical solutions market data book summary
| Market revenue in 2023 | USD 595.6 million |
| Market revenue in 2030 | USD 1,657.2 million |
| Growth rate | 15.7% (CAGR from 2023 to 2030) |
| Largest segment | Ctms |
| Fastest growing segment | ECOA |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical Data Integration Platforms, Safety solutions, CTMS, RTSM, ETMF, EConsent |
| Key market players worldwide | DATATRAK International Inc, Oracle Corp, PAREXEL, Dassault Systemes SE, Signant Health, Clario, eClinicalWorks, International Business Machines Corp, IQVIA Holdings Inc, Veeva Systems Inc Class A, Anju Software, MaxisIT Inc., Castor |
Other key industry trends
- In terms of revenue, China accounted for 4.3% of the global eclinical solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan eclinical solutions market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,612.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
EClinical Solutions Market Scope
EClinical Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China eclinical solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eclinical solutions market will help companies and investors design strategic landscapes.
Ctms was the largest segment with a revenue share of 22.68% in 2023. Horizon Databook has segmented the China eclinical solutions market based on ecoa, edc & cdms, clinical analytics platforms, clinical data integration platforms, safety solutions, ctms, rtsm, etmf, econsent covering the revenue growth of each sub-segment from 2018 to 2030.
China is considered as one amongst the high healthcare spending countries, which will aid in expanding investment opportunities pertaining to clinical research. Major medical device companies in China are focusing on clinical research and, hence, creating more demand for clinical trial management systems. In 2015, China conducted 722 clinical trials and is expected to increase every year.
Chinese clinical trial and drug registration fees has increased significantly, which might have a positive impact on the Chinese trial market but can discourage global companies from registering a new drug. China does have immense growth opportunities owing to high population base and improved healthcare facilities on the grounds of untargeted medical needs.
Reasons to subscribe to China eclinical solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China eclinical solutions market databook
-
Our clientele includes a mix of eclinical solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China eclinical solutions market , including forecasts for subscribers. This country databook contains high-level insights into China eclinical solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China eclinical solutions market size, by product, 2018-2030 (US$M)
China EClinical Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
